Internet-based Support for Young People With ADHD & Autism

Status Completed

Clinical Trial Summary

Young people between age 15 and 25 with ADHD and/or autism spectrum disorders are offered internet-based support and coaching during eight weeks (chat and e-mail). Data is collected before and after the intervention and six months after end of treatment using self-report questionnaires pertaining to sense of coherence, self-esteem, quality of life, depressive and anxiety symptoms and socioeconomic status. Parents complete an assessment scale for the next of kin. After treatment the young people are interviewed regarding the quality of the intervention. A comparison group matched for age, gender and neuropsychiatric diagnosis is offered treatment as usual and is assessed at the same time points as the intervention group. The individuals are not randomized due to difficulties to recruit if the individuals do not know group assignment in advance.

Clinical Trial Description

Young people between age 15 and 25 with ADHD and/or autism spectrum disorders are consecutively included in the project and are offered coaching and support during eight weeks over the internet (chat and e-mail) twice a week. Data is collected before and after the intervention as well as six months after end of treatment using self-report questionnaires (Sense of Coherence (SOC), Rosenberg Self Esteem Scale, Manchester Short Assessment of Quality of Life (MANSA), Montgomery Asberg Depression Rating Scale (MADRS), and Hospital Anxiety and Depression Scale (HAD)). A parent or a partner completes an assessment scale for the next of kin. When treatment is completed, the young people are interviewed using a structured interview pertaining to the quality of the intervention. A comparison group matched for age, gender and neuropsychiatric diagnosis is offered treatment as usual (TAU) and is assessed at the same time points as the intervention group. The individuals are not randomized to the intervention and comparison groups due to difficulties to recruit if the individuals do not know group assignment in advance. In all, 24 individuals will be offered the intervention and 24 individuals will receive TAU. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT02300597
Study type	Interventional
Source	Göteborg University
Contact
Status	Completed
Phase	N/A
Start date	September 2010
Completion date	June 2015

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT03148782` - Brain Plasticity Underlying Acquisition of New Organizational Skills in Children-R61 Phase	N/A
Recruiting	`NCT06038942` - Formal Versus Informal Mindfulness Among University Students With Self-reported ADHD, Nonsuicidal Self-injury, or Stress	N/A
Not yet recruiting	`NCT06456372` - Digital Health Intervention for Children With ADHD	N/A
Completed	`NCT05518435` - Managing Young People With ADHD in Primary Care Study
Active, not recruiting	`NCT04978792` - Does Cultivating Self-compassion Improve Resilience to Criticism and Improve Mental Health in Adults With ADHD?	N/A
Completed	`NCT03216512` - Effects of Noise Cancelling Headphones on Neurocognitive and Academic Outcomes in ADHD	N/A
Not yet recruiting	`NCT02906501` - Effect of Risperidone on Cognitive Functions in Adolescents With ADHD and Behavioral Disturbances	N/A
Completed	`NCT02900144` - Modified Comprehensive Behavioral Intervention for Tics (M_CBIT)	N/A
Completed	`NCT02829528` - Little Flower Yoga for Kids: Evaluation of a Yoga and Mindfulness Program for Children With Increased Levels of Emotion Dysregulation and Inattention	N/A
Completed	`NCT02562469` - ACTIVATE: A Computerized Training Program for Children With ADHD	N/A
Terminated	`NCT02271880` - Improving Medication Adherence in ADHD Adolescents	N/A
Recruiting	`NCT02255565` - Dose Response Effects of Quillivant XR in Children With ADHD and Autism: A Pilot Study	Phase 4
Completed	`NCT02463396` - Mindfulness Training in Adults With ADHD	N/A
Completed	`NCT01673594` - Prevention of Stimulant-Induced Euphoria With an Opioid Receptor Antagonist	Phase 4
Terminated	`NCT01733680` - Amiloride Hydrochloride as an Effective Treatment for ADHD	Early Phase 1
Active, not recruiting	`NCT01137318` - Combined Cognitive Remediation and Behavioral Intervention for Treatment of Attention-deficit/Hyperactivity Disorder (ADHD)	Phase 2
Completed	`NCT01404273` - Functional MRI of Relaxation Response Training in Adults With Attention-Deficit/Hyperactivity Disorder	N/A
Completed	`NCT00586157` - Study of Medication Patch to Treat Children Ages 6-12 With ADHD	Phase 4
Completed	`NCT00573859` - The Reinforcing Mechanisms of Smoking in Adult ADHD	Phase 1/Phase 2
Completed	`NCT00228540` - Study to Assess Satisfaction With Modafinil Treatment in Children and Adolescents With ADHD	Phase 3

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Internet-based Support for Young People With ADHD and Autism - a Controlled Study

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms